Patricia Callahan

The Booster Seat Safety Act was prompted by a ProPublica investigation and a subsequent congressional probe that found manufacturers had misled parents about the safety of booster seats and endangered children’s lives.

After ProPublica revealed that some wealthy Americans hold Roth IRAs worth hundreds of millions — compared to $39,000 for the average account holder — Democrats requested data. It shows more than 28,000 people with IRAs worth $5 million or more.

A co-leader of a group of 18 attorneys general calls ProPublica’s story about the lack of side-impact tests for children’s booster seats “horrifying” and says it’s about time federal regulators stepped in to protect kids.

The congressional subcommittee launched its inquiry in response to a ProPublica investigation, finding several companies created tests that were “nearly impossible to fail.” Now it’s asking state and federal regulators to investigate too.

The congressional subcommittee launched its inquiry in response to a ProPublica investigation, finding several companies created tests that were “nearly impossible to fail.” Now it’s asking state and federal regulators to investigate too.

Following a ProPublica investigation, members of Congress say “unsafe” booster seats are being sold to parents while regulators fail to protect children.

The government overpaid by hundreds of millions for Philips ventilators, says a House investigation spurred by ProPublica reporting. Now that deal is off and Congress is scrutinizing other coronavirus deals made by trade adviser Peter Navarro.

The government overpaid by hundreds of millions for Philips ventilators, says a House investigation spurred by ProPublica reporting. Now that deal is off and Congress is scrutinizing other coronavirus deals made by trade adviser Peter Navarro.

A House panel says “gullible” White House negotiators overpaid for Phillips ventilators, and it has asked the Department of Health and Human Services Office of Inspector General to investigate evidence of fraud in the deal.

A congressional subcommittee is questioning a federal decision to pay quadruple the price for the commercial version of a ventilator Royal Philips N.V. had developed with taxpayer funds.